Skip Navigation


Journal of Biochemistry Advance Access originally published online on August 18, 2006
Journal of Biochemistry 2006 140(4):509-515; doi:10.1093/jb/mvj179
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
140/4/509    most recent
mvj179v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Takahashi-Ando, N.
Right arrow Articles by Nishi, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takahashi-Ando, N.
Right arrow Articles by Nishi, Y.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2006 The Japanese Biochemical Society.

ARTICLE

Molecular Mechanisms of Improvement of Hydrolytic Antibody 6D9 by Site-Directed Mutagenesis

Naoko Takahashi-Ando1,*,{dagger}, Kazuko Shimazaki1,*, Hiroyuki Kakinuma1,*, Ikuo Fujii2,* and Yoshisuke Nishi1,*,{dagger}

1 Laboratory of Life Science & Biomolecular Engineering, Japan Tobacco, Inc. 6-2, Umegaoka, Aoba-ku, Yokohama, Kanagawa 227-8512; and 2 Department of Biological Science, Graduate School of Science, Osaka Prefecture University, 1-2, Gakuen-cho, Sakai, Osaka 599-8570

* Present addresses: Naoko Takahashi-Ando, Plant & Microbial Metabolic Engineering Research Unit, RIKEN, 2-1, Hirosawa, Wako, Saitama 351-0198; Kazuko Shimazaki, Nippon Veterinary and Life Science University, Department of Veterinary, Laboratory of Structural Bioinformatics, 1-7-1, Kyonan-cho, Musashino, Tokyo 180-8602; Hiroyuki Kakinuma, Medicinal Chemistry Laboratory, Taisho Pharmaceutical CO., LTD., 1-403, Yoshino-cho, Saitama, Saitama 330-8530; Yoshisuke Nishi, Faculty of Bioscience, Nagahama Institute of Bio-Science and Technology, 1266 Tamura-cho, Nagahama, Shiga 526-0829.

We performed a series of site-directed mutagenesis experiments of catalytic antibody, 6D9, which hydrolyzes a prodrug of chloramphenicol, based on our previous directed evolution study [Takahashi et al. (2001) Nat. Biotechnol. 19, 563–567]. Since we previously found that the variants with a mutation of Ser(L27e)Tyr afforded a one order of magnitude increase in catalytic rate, we created a site-directed mutant containing this mutation. The resulting mutant, 6D9-Ser(L27e)Tyr, had 6.5-fold higher kcat/kuncat and 9.8-fold higher kcat/Km than wild-type 6D9. We also created 6D9-Thr(L27a)Pro, since this mutation occurred frequently in the previous directed evolution, and it had 2.1-fold higher kcat/kuncat and kcat/Km than 6D9. Kinetic and computational analyses suggest that Tyr at L27e contributes to transition-state stabilization, while Pro at L27a does not interact with the transition-state structure directly, but obviously contributes to enhanced catalytic activity. Including double mutants that combined favourable substitutions, we created seven site-directed mutants. However, none of them had higher catalytic activities than some of highly improved variants obtained in the previous directed evolution. The present study gives direct evidence that not only a specific amino acid residue which obviously contributes to transition-state stabilization, but also a group of amino acid residues working in concert is important for efficient catalysis of a given transformation.

{dagger}To whom correspondence should be addressed. Naoko Takahashi-Ando, Tel: +81-48-467-9796, E-mail: ntando{at}postman.riken.jp; Yoshisuke Nishi, Tel: +81-749-64-8122 (direct line)/+81-749-64-8100 (main line), Fax: +81-749-64-8140, E-mail: y_nishi{at}nagahama-i-bio.ac.jp


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.